世界の点眼薬市場2021-2026:網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬

LP Informationが発行した調査報告書(LPI21MY9609)
◆英語タイトル:Global Ophthalmol Drugs Market Growth 2021-2026
◆商品コード:LPI21MY9609
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月
◆ページ数:139
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥494,100見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥741,150見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥988,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「点眼薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬など、用途別には、緑内障、ドライアイ症候群、網膜疾患、その他などにセグメント区分してまとめました。点眼薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・点眼薬の世界市場概要(サマリー)
・点眼薬の企業別販売量・売上
・点眼薬の企業別市場シェア
・点眼薬の世界市場規模 2016年-2021年:種類別(網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬)
・点眼薬の世界市場規模 2016年-2021年:用途別(緑内障、ドライアイ症候群、網膜疾患、その他)
・点眼薬の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・点眼薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・点眼薬のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・点眼薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・点眼薬市場の成長要因・課題・動向
・点眼薬の世界市場予測 2021年-2026年
・点眼薬の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・点眼薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・点眼薬のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・点眼薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・点眼薬の世界市場予測:種類別(網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬)
・点眼薬の世界市場予測:用途別(緑内障、ドライアイ症候群、網膜疾患、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Ophthalmol Drugs will have significant change from previous year. By the most conservative estimates of global Ophthalmol Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Ophthalmol Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmol Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Retinal Disorders Drugs
Allergic, Inflammatory and Infective Drugs
Glaucoma Drugs
Dry Eye Drugs

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Glaucoma
Dry Eye Syndrome
Retinal Diseases
Other Ophthalmic Indications

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmol Drugs Consumption 2016-2026
2.1.2 Ophthalmol Drugs Consumption CAGR by Region
2.2 Ophthalmol Drugs Segment by Type
2.2.1 Retinal Disorders Drugs
2.2.2 Allergic, Inflammatory and Infective Drugs
2.2.3 Glaucoma Drugs
2.2.4 Dry Eye Drugs
2.3 Ophthalmol Drugs Sales by Type
2.3.1 Global Ophthalmol Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Ophthalmol Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Ophthalmol Drugs Sale Price by Type (2016-2021)
2.4 Ophthalmol Drugs Segment by Application
2.4.1 Glaucoma
2.4.2 Dry Eye Syndrome
2.4.3 Retinal Diseases
2.4.4 Other Ophthalmic Indications
2.5 Ophthalmol Drugs Sales by Application
2.5.1 Global Ophthalmol Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Ophthalmol Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Ophthalmol Drugs Sale Price by Application (2016-2021)

3 Global Ophthalmol Drugs by Company
3.1 Global Ophthalmol Drugs Sales Market Share by Company
3.1.1 Global Ophthalmol Drugs Sales by Company (2019-2021)
3.1.2 Global Ophthalmol Drugs Sales Market Share by Company (2019-2021)
3.2 Global Ophthalmol Drugs Revenue Market Share by Company
3.2.1 Global Ophthalmol Drugs Revenue by Company (2019-2021)
3.2.2 Global Ophthalmol Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Ophthalmol Drugs Sale Price by Company
3.4 Global Manufacturers Ophthalmol Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmol Drugs Product Location Distribution
3.4.2 Players Ophthalmol Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Ophthalmol Drugs by Region
4.1 Global Ophthalmol Drugs by Region
4.1.1 Global Ophthalmol Drugs Sales by Region
4.1.2 Global Ophthalmol Drugs Revenue by Region
4.2 Americas Ophthalmol Drugs Sales Growth
4.3 APAC Ophthalmol Drugs Sales Growth
4.4 Europe Ophthalmol Drugs Sales Growth
4.5 Middle East & Africa Ophthalmol Drugs Sales Growth

5 Americas
5.1 Americas Ophthalmol Drugs Sales by Country
5.1.1 Americas Ophthalmol Drugs Sales by Country (2016-2021)
5.1.2 Americas Ophthalmol Drugs Revenue by Country (2016-2021)
5.2 Americas Ophthalmol Drugs Sales by Type
5.3 Americas Ophthalmol Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Ophthalmol Drugs Sales by Region
6.1.1 APAC Ophthalmol Drugs Sales by Region (2016-2021)
6.1.2 APAC Ophthalmol Drugs Revenue by Region (2016-2021)
6.2 APAC Ophthalmol Drugs Sales by Type
6.3 APAC Ophthalmol Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Ophthalmol Drugs by Country
7.1.1 Europe Ophthalmol Drugs Sales by Country (2016-2021)
7.1.2 Europe Ophthalmol Drugs Revenue by Country (2016-2021)
7.2 Europe Ophthalmol Drugs Sales by Type
7.3 Europe Ophthalmol Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Ophthalmol Drugs by Country
8.1.1 Middle East & Africa Ophthalmol Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Ophthalmol Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Ophthalmol Drugs Sales by Type
8.3 Middle East & Africa Ophthalmol Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Ophthalmol Drugs Distributors
10.3 Ophthalmol Drugs Customer

11 Global Ophthalmol Drugs Market Forecast
11.1 Global Ophthalmol Drugs Forecast by Region
11.1.1 Global Ophthalmol Drugs Forecast by Regions (2021-2026)
11.2.2 Global Ophthalmol Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Ophthalmol Drugs Forecast by Type
11.7 Global Ophthalmol Drugs Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Novartis Novartis Company Information
12.1.2 Novartis Ophthalmol Drugs Product Offered
12.1.3 Novartis Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Novartis Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Allergan
12.2.1 Allergan Company Information
12.2.2 Allergan Ophthalmol Drugs Product Offered
12.2.3 Allergan Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Allergan Main Business Overview
12.2.5 Allergan Latest Developments
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Ophthalmol Drugs Product Offered
12.3.3 Roche Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Roche Main Business Overview
12.3.5 Roche Latest Developments
12.4 Valeant
12.4.1 Valeant Company Information
12.4.2 Valeant Ophthalmol Drugs Product Offered
12.4.3 Valeant Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Valeant Main Business Overview
12.4.5 Valeant Latest Developments
12.5 Regeneron
12.5.1 Regeneron Company Information
12.5.2 Regeneron Ophthalmol Drugs Product Offered
12.5.3 Regeneron Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Regeneron Main Business Overview
12.5.5 Regeneron Latest Developments
12.6 Santen
12.6.1 Santen Company Information
12.6.2 Santen Ophthalmol Drugs Product Offered
12.6.3 Santen Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Santen Main Business Overview
12.6.5 Santen Latest Developments
12.7 Bayer
12.7.1 Bayer Company Information
12.7.2 Bayer Ophthalmol Drugs Product Offered
12.7.3 Bayer Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Bayer Main Business Overview
12.7.5 Bayer Latest Developments
12.8 Pfizer
12.8.1 Pfizer Company Information
12.8.2 Pfizer Ophthalmol Drugs Product Offered
12.8.3 Pfizer Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Pfizer Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 Senju
12.9.1 Senju Company Information
12.9.2 Senju Ophthalmol Drugs Product Offered
12.9.3 Senju Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Senju Main Business Overview
12.9.5 Senju Latest Developments
12.10 Akorn
12.10.1 Akorn Company Information
12.10.2 Akorn Ophthalmol Drugs Product Offered
12.10.3 Akorn Ophthalmol Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Akorn Main Business Overview
12.10.5 Akorn Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Ophthalmol Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Retinal Disorders Drugs
Table 3. Major Players of Allergic, Inflammatory and Infective Drugs
Table 4. Major Players of Glaucoma Drugs
Table 5. Major Players of Dry Eye Drugs
Table 6. Global Ophthalmol Drugs Sales by Type (2016-2021) & (K MT)
Table 7. Global Ophthalmol Drugs Sales Market Share by Type (2016-2021)
Table 8. Global Ophthalmol Drugs Revenue by Type (2016-2021) & ($ million)
Table 9. Global Ophthalmol Drugs Revenue Market Share by Type (2016-2021)
Table 10. Global Ophthalmol Drugs Sale Price by Type (2016-2021)
Table 11. Global Ophthalmol Drugs Sales by Application (2016-2021) & (K MT)
Table 12. Global Ophthalmol Drugs Sales Market Share by Application (2016-2021)
Table 13. Global Ophthalmol Drugs Value by Application (2016-2021)
Table 14. Global Ophthalmol Drugs Revenue Market Share by Application (2016-2021)
Table 15. Global Ophthalmol Drugs Sale Price by Application (2016-2021)
Table 16. Global Ophthalmol Drugs Sales by Company (2019-2021) & (K MT)
Table 17. Global Ophthalmol Drugs Sales Market Share by Company (2019-2021)
Table 18. Global Ophthalmol Drugs Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Ophthalmol Drugs Revenue Market Share by Company (2019-2021)
Table 20. Global Ophthalmol Drugs Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Ophthalmol Drugs Producing Area Distribution and Sales Area
Table 22. Players Ophthalmol Drugs Products Offered
Table 23. Ophthalmol Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Ophthalmol Drugs Sales by Region (2016-2021) (K MT)
Table 27. Global Ophthalmol Drugs Sales Market Share by Region (2016-2021)
Table 28. Global Ophthalmol Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Ophthalmol Drugs Revenue Market Share by Region (2016-2021)
Table 30. Americas Ophthalmol Drugs Sales by Country (2016-2021) & (K MT)
Table 31. Americas Ophthalmol Drugs Sales Market Share by Country (2016-2021)
Table 32. Americas Ophthalmol Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Ophthalmol Drugs Revenue Market Share by Country (2016-2021)
Table 34. Americas Ophthalmol Drugs Sales by Type (2016-2021) & (K MT)
Table 35. Americas Ophthalmol Drugs Sales Market Share by Type (2016-2021)
Table 36. Americas Ophthalmol Drugs Sales by Application (2016-2021) & (K MT)
Table 37. Americas Ophthalmol Drugs Sales Market Share by Application (2016-2021)
Table 38. APAC Ophthalmol Drugs Sales by Region (2016-2021) & (K MT)
Table 39. APAC Ophthalmol Drugs Sales Market Share by Region (2016-2021)
Table 40. APAC Ophthalmol Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Ophthalmol Drugs Revenue Market Share by Region (2016-2021)
Table 42. APAC Ophthalmol Drugs Sales by Type (2016-2021) & (K MT)
Table 43. APAC Ophthalmol Drugs Sales Market Share by Type (2016-2021)
Table 44. APAC Ophthalmol Drugs Sales by Application (2016-2021) & (K MT)
Table 45. APAC Ophthalmol Drugs Sales Market Share by Application (2016-2021)
Table 46. Europe Ophthalmol Drugs Sales by Country (2016-2021) & (K MT)
Table 47. Europe Ophthalmol Drugs Sales Market Share by Country (2016-2021)
Table 48. Europe Ophthalmol Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Ophthalmol Drugs Revenue Market Share by Country (2016-2021)
Table 50. Europe Ophthalmol Drugs Sales by Type (2016-2021) & (K MT)
Table 51. Europe Ophthalmol Drugs Sales Market Share by Type (2016-2021)
Table 52. Europe Ophthalmol Drugs Sales by Application (2016-2021) & (K MT)
Table 53. Europe Ophthalmol Drugs Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Ophthalmol Drugs Sales by Country (2016-2021) & (K MT)
Table 55. Middle East & Africa Ophthalmol Drugs Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Ophthalmol Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Ophthalmol Drugs Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Ophthalmol Drugs Sales by Type (2016-2021) & (K MT)
Table 59. Middle East & Africa Ophthalmol Drugs Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Ophthalmol Drugs Sales by Application (2016-2021) & (K MT)
Table 61. Middle East & Africa Ophthalmol Drugs Sales Market Share by Application (2016-2021)
Table 62. Global Ophthalmol Drugs Sales Forecast by Type (2021-2026) & (K MT)
Table 63. Global Ophthalmol Drugs Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Ophthalmol Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Ophthalmol Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Ophthalmol Drugs Sales Forecast by Application (2021-2026) & (K MT)
Table 67. Global Ophthalmol Drugs Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Ophthalmol Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Ophthalmol Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 70. Novartis Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 71. Novartis Ophthalmol Drugs Product Offered
Table 72. Novartis Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 73. Novartis Main Business
Table 74. Novartis Latest Developments
Table 75. Allergan Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Allergan Ophthalmol Drugs Product Offered
Table 77. Allergan Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 78. Allergan Main Business
Table 79. Allergan Latest Developments
Table 80. Roche Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Roche Ophthalmol Drugs Product Offered
Table 82. Roche Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Valeant Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Valeant Ophthalmol Drugs Product Offered
Table 87. Valeant Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 88. Valeant Main Business
Table 89. Valeant Latest Developments
Table 90. Regeneron Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Regeneron Ophthalmol Drugs Product Offered
Table 92. Regeneron Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 93. Regeneron Main Business
Table 94. Regeneron Latest Developments
Table 95. Santen Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Santen Ophthalmol Drugs Product Offered
Table 97. Santen Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 98. Santen Main Business
Table 99. Santen Latest Developments
Table 100. Bayer Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Bayer Ophthalmol Drugs Product Offered
Table 102. Bayer Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 103. Bayer Main Business
Table 104. Bayer Latest Developments
Table 105. Pfizer Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Ophthalmol Drugs Product Offered
Table 107. Pfizer Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Senju Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Senju Ophthalmol Drugs Product Offered
Table 112. Senju Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 113. Senju Main Business
Table 114. Senju Latest Developments
Table 115. Akorn Basic Information, Ophthalmol Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Akorn Ophthalmol Drugs Product Offered
Table 117. Akorn Ophthalmol Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 118. Akorn Main Business
Table 119. Akorn Latest Developments
List of Figures
Figure 1. Picture of Ophthalmol Drugs
Figure 2. Ophthalmol Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmol Drugs Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Ophthalmol Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Ophthalmol Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Retinal Disorders Drugs
Figure 10. Product Picture of Allergic, Inflammatory and Infective Drugs
Figure 11. Product Picture of Glaucoma Drugs
Figure 12. Product Picture of Dry Eye Drugs
Figure 13. Global Ophthalmol Drugs Sales Market Share by Type in 2020
Figure 14. Global Ophthalmol Drugs Revenue Market Share by Type (2016-2021)
Figure 15. Ophthalmol Drugs Consumed in Glaucoma
Figure 16. Global Ophthalmol Drugs Market: Glaucoma (2016-2021) & (K MT)
Figure 17. Ophthalmol Drugs Consumed in Dry Eye Syndrome
Figure 18. Global Ophthalmol Drugs Market: Dry Eye Syndrome (2016-2021) & (K MT)
Figure 19. Ophthalmol Drugs Consumed in Retinal Diseases
Figure 20. Global Ophthalmol Drugs Market: Retinal Diseases (2016-2021) & (K MT)
Figure 21. Ophthalmol Drugs Consumed in Other Ophthalmic Indications
Figure 22. Global Ophthalmol Drugs Market: Other Ophthalmic Indications (2016-2021) & (K MT)
Figure 23. Global Ophthalmol Drugs Sales Market Share by Application (2016-2021)
Figure 24. Global Ophthalmol Drugs Revenue Market Share by Application in 2020
Figure 25. Global Ophthalmol Drugs Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Ophthalmol Drugs Revenue Market Share by Company in 2020
Figure 27. Global Ophthalmol Drugs Sales Market Share by Regions (2016-2021)
Figure 28. Global Ophthalmol Drugs Revenue Market Share by Region in 2020
Figure 29. Americas Ophthalmol Drugs Sales 2016-2021 (K MT)
Figure 30. Americas Ophthalmol Drugs Revenue 2016-2021 ($ Millions)
Figure 31. APAC Ophthalmol Drugs Sales 2016-2021 (K MT)
Figure 32. APAC Ophthalmol Drugs Revenue 2016-2021 ($ Millions)
Figure 33. Europe Ophthalmol Drugs Sales 2016-2021 (K MT)
Figure 34. Europe Ophthalmol Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Ophthalmol Drugs Sales 2016-2021 (K MT)
Figure 36. Middle East & Africa Ophthalmol Drugs Revenue 2016-2021 ($ Millions)
Figure 37. Americas Ophthalmol Drugs Sales Market Share by Country in 2020
Figure 38. Americas Ophthalmol Drugs Revenue Market Share by Country in 2020
Figure 39. Americas Ophthalmol Drugs Sales Market Share by Type in 2020
Figure 40. Americas Ophthalmol Drugs Sales Market Share by Application in 2020
Figure 41. United States Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Ophthalmol Drugs Sales Market Share by Region in 2020
Figure 46. APAC Ophthalmol Drugs Revenue Market Share by Regions in 2020
Figure 47. APAC Ophthalmol Drugs Sales Market Share by Type in 2020
Figure 48. APAC Ophthalmol Drugs Sales Market Share by Application in 2020
Figure 49. China Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Ophthalmol Drugs Sales Market Share by Country in 2020
Figure 56. Europe Ophthalmol Drugs Revenue Market Share by Country in 2020
Figure 57. Europe Ophthalmol Drugs Sales Market Share by Type in 2020
Figure 58. Europe Ophthalmol Drugs Sales Market Share by Application in 2020
Figure 59. Germany Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Ophthalmol Drugs Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Ophthalmol Drugs Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Ophthalmol Drugs Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Ophthalmol Drugs Sales Market Share by Application in 2020
Figure 68. Egypt Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Ophthalmol Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の点眼薬市場2021-2026:網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬(Global Ophthalmol Drugs Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。